Suboxone | Addiction Professional Magazine Skip to content Skip to navigation

Suboxone

Opioid treatment programs growing, and expanding into other medications

August 23, 2017  |  Gary A. Enos, Editor
news
Today's opioid treatment programs (OTPs) are increasingly likely to be offering buprenorphine and injectable naltrexone treatment in addition to methadone.

NCAD: Doctor attacks misconceptions about opioid addiction medications

August 20, 2017  |  Gary A. Enos, Editor
article
The owner of Addiction Recovery Resources in Louisiana discussed why it makes sense to integrate 12-Step and medication approaches to opioid addiction treatment.

Stigma apparent in physician replies to survey on buprenorphine prescribing

August 8, 2017  |  Gary A. Enos, Editor
article
A 2016 physician survey on the prescribing of buprenorphine does indicate that counselors and other specialty providers could help physicians overcome reluctance to prescribe the opioid dependence treatment.

Partnership in R.I. will accelerate buprenorphine training

July 13, 2017  |  Gary A. Enos, Editor
article
An expanded addictions curriculum in Brown University's medical school will allow some young doctors to qualify immediately to prescribe buprenorphine for opioid dependence.

Place medication in the rightful context

June 27, 2017  |  Gary A. Enos, Editor
blog
A number of experts in the addiction field would like to see use of the term "medication-assisted treatment" eradicated, saying that it perpetuates stigma.

Few young people with opioid dependence have received medication

June 21, 2017  |  Gary A. Enos, Editor
news
A Boston Medical Center study has found that just over one-quarter of adolescents and young adults diagnosed with an opioid use disorder from 2001-2014 received a prescription for buprenorphine or naltrexone.

Research will apply technology to improve buprenorphine compliance

June 20, 2017  |  Gary A. Enos, Editor
article
The National Institute on Drug Abuse (NIDA) is funding a study that will determine whether direct observation of patients receiving buprenorphine treatment can improve retention in treatment and drug use outcomes.

Total transformation: Phoenix House will dramatically move beyond TC roots

May 23, 2017  |  Gary A. Enos, Editor
article
New Phoenix Life Centers in New York City this summer will signal a major clinical shift for one of the nation's most prominent nonprofit addiction treatment organizations.

Rx Summit: Unlikely political duo teams up for science-based care

April 19, 2017  |  Gary A. Enos, Editor
article
Newt Gingrich and Patrick Kennedy have at least one thing in common: an absolute reverence for brain research that can inform solutions to the opioid crisis.

Brightside Clinic hires medical director

March 20, 2017  |  Gary A. Enos, Editor
news
David Kushner, DO, FACP, has been named medical director at Brightside Clinic, the buprenorphine treatment organization with offices in two Illinois communities.

Study highlights threat of dual use of buprenorphine and other opioids

March 7, 2017  |  Rachael Zimlich, RN, Contributing Writer
article
Research using a pharmacy database leads to striking findings about the prevalence of other opioid use during and after buprenorphine treatment.

Readers open to idea of marijuana-inclusive treatment

February 28, 2017  |  Tom Valentino, Senior Editor
blog
Our story last week on the use of marijuana in addiction treatment has generated a lot of reader feedback, with many commenters willing to consider the practice.

Pages

Subscribe to Suboxone